Pideka expects to have five 1,200 m2 warehouses by the end of this year, after investing nearly US $15 million.
Pideka, a Colombian company that is a pioneer in indoor medicinal cannabis cultivation, will start its first phase of operations in the country this month with the construction of its first five warehouses and an initial investment of US $3 million.
The company has 20 years of experience in research and development of different varieties of cannabis for medicinal use. Its production is unique and cutting-edge in Colombia, as it is the first crop of this kind that is grown under light and humidity controlled conditions in the country.
"We control all temperature and humidity conditions to ensure that the production conditions are right and that the cannabis achieves having the specific compositions for the treatment of different diseases, such as epilepsy, chronic pain, autoimmune diseases, and that it can be used as a palliative treatment in diseases such as cancer,” stated Denis Contri, who is responsible for the company’s production and scientific research.
This allows the company to ensure the standardization and safety of its crops, which are rigorously selected, and the production of different concentrations of compounds and high-quality plant varieties, that allows them to provide their users with a great experience and better welfare conditions.
"This cultivation technique helps us control challenging issues, such as moisture or fungi, so that we can grow the medicinal crops in optimal conditions. Our goal is to surpass current international standards by providing high quality medicinal cannabis and derivatives to foreign and domestic companies with licenses to manufacture or market such products,” he said.
The company's has already sold its first crop production, which is estimated will be harvested in the first half of 2019, in its entirety to different laboratories and investors who have bet on the company's superior quality product.
Pideka plans to have five 1,200 m2 warehouses by the end of 2019, after investing nearly US $15 million and generating more than 100 new jobs.
At present, thanks to Law 1787 of 2016, it is legal to use the marijuana plant for medicinal purposes in the country.
The regulations for manufacturing, using seeds, and cultivating cannabis were enacted about a year ago and, up until last month, there are some 230 companies licensed to produce medicinal cannabis in 15 departments in the country.